Cargando…
Development and validation of an ECM-related prognostic signature to predict the immune landscape of human hepatocellular carcinoma
BACKGROUND: The global burden of hepatocellular carcinoma (HCC) is increasing, negatively impacting social health and economies. The discovery of novel and valuable biomarkers for the early diagnosis and therapeutic guidance of HCC is urgently needed. METHODS: Extracellular matrix (ECM)-related gene...
Autores principales: | Wu, Guozhi, Yang, Yuan, Ye, Rong, Yue, Hanxun, Zhang, Huiyun, Huang, Taobi, Liu, Min, Zheng, Ya, Wang, Yuping, Zhou, Yongning, Guo, Qinghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531523/ https://www.ncbi.nlm.nih.gov/pubmed/36195857 http://dx.doi.org/10.1186/s12885-022-10049-w |
Ejemplares similares
-
Comprehensive Analysis to Identify the Epithelial–Mesenchymal Transition-Related Immune Signatures as a Prognostic and Therapeutic Biomarkers in Hepatocellular Carcinoma
por: Wu, Guozhi, et al.
Publicado: (2021) -
Comprehensive analysis of gene regulation network and immune signatures of prognostic biomarker YAP1 in pancreatic cancer
por: Yang, Yuan, et al.
Publicado: (2020) -
Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma
por: Yang, Yuan, et al.
Publicado: (2021) -
In silico development and validation of a novel glucose and lipid metabolism-related gene signature in gastric cancer
por: Yang, Yuan, et al.
Publicado: (2022) -
Integrated pan-cancer analysis of CSMD2 as a potential prognostic, diagnostic, and immune biomarker
por: Zhang, Huiyun, et al.
Publicado: (2022)